Literature DB >> 18032977

How relevant are cytokines in colorectal cancer wasting?

Paula Ravasco1, Isabel Monteiro-Grillo, Maria Camilo.   

Abstract

PURPOSE: The purpose of this article was to investigate the influence of inflammatory cytokines, pro-cachectic (interleukin [IL]-1 receptor agonist [IL-1ra], IL-6, and tumor necrosis factor-alpha [TNF-alpha]), immunomodulatory (IL-10 and interferon-gamma [IFN-gamma]), and pro-angiogenic (vascular endothelial growth factor [VEGF]), on resting energy expenditure (REE), weight, and nutritional intake and to explore potential interactions between their circulating concentrations and colorectal cancer stage/histologic differentiation and response to radiotherapy (RT). PATIENTS AND METHODS: This was a prospective longitudinal study in 101 patients evaluated before and after neoadjuvant RT, including REE (indirect calorimetry), percent weight loss, usual/current diet (diet history and 24-hour recall), serum concentrations of cytokines (enzyme-linked immunosorbent assay), and RT response.
RESULTS: Stages III/IV were often associated with histologic grades 2/3 (P < 0.01), albeit both characteristics independently were associated with higher concentrations of IL-1ra (P </= 0.05), IL-6 (P </= 0.02), TNF-alpha (P </= 0.05), IFN-gamma (P </= 0.05), and VEGF (P < 0.03). Before and after RT, higher REE, weight loss >/=5%, and intake reduction >/=25% were associated with advanced stage, histologic grades 2/3, higher IL-1ra, IL-6, TNF-alpha, IFN-gamma, and VEGF, and nonresponse to RT (P = 0.003). A general linear model analysis showed that stages III/IV, histologic grades 2/3, and higher IL-1ra, IL-6, TNF-alpha, IFN-gamma, and VEGF were major determinants of REE increase, weight loss, and intake reduction. In predictive value analyses, higher baseline pro-cachectic cytokines (IL-1ra + IL-6 + TNF-alpha) by themselves predicted increased REE (hazard ratio [HR]: 8.25; 95% CI: 2.74-26.47; P < 0.002), greater weight loss (HR: 8.15; 95% CI: 2.22-25.40; P < 0.002), and intake reductions (HR: 7.15; 95% CI: 2.25-16.11; P < 0.004) after RT.
CONCLUSION: This study confirms the fact that wasting in colorectal cancer is correlated with tumor burden and histologic aggressiveness and suggests that both characteristics lead to overproduction of IFN-gamma, VEGF, and pro-cachectic cytokines, all of which may cause higher metabolic rates, poor intake, and nonresponse to RT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032977     DOI: 10.1097/PPO.0b013e3181594940

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  8 in total

1.  Total energy expenditure in patients with colorectal cancer: associations with body composition, physical activity, and energy recommendations.

Authors:  Sarah A Purcell; Sarah A Elliott; Peter J Walter; Tom Preston; Hongyi Cai; Richard J E Skipworth; Michael B Sawyer; Carla M Prado
Journal:  Am J Clin Nutr       Date:  2019-08-01       Impact factor: 7.045

Review 2.  Key determinants of energy expenditure in cancer and implications for clinical practice.

Authors:  S A Purcell; S A Elliott; V E Baracos; Q S C Chu; C M Prado
Journal:  Eur J Clin Nutr       Date:  2016-06-08       Impact factor: 4.016

3.  The diversity of nutritional status in cancer: new insights.

Authors:  Mariana Ramos Chaves; Carolina Boléo-Tomé; Isabel Monteiro-Grillo; Maria Camilo; Paula Ravasco
Journal:  Oncologist       Date:  2010-04-15

4.  Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer.

Authors:  Patrizia Ferroni; Silvia Riondino; Ilaria Portarena; Vincenzo Formica; Francesca La Farina; Francesca Martini; Gioia Massimiani; Raffaele Palmirotta; Fiorella Guadagni; Mario Roselli
Journal:  Int J Colorectal Dis       Date:  2012-05-12       Impact factor: 2.571

5.  Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways.

Authors:  Rafael Barreto; Giorgia Mandili; Frank A Witzmann; Francesco Novelli; Teresa A Zimmers; Andrea Bonetto
Journal:  Front Physiol       Date:  2016-10-19       Impact factor: 4.566

6.  A systematic review of the overlap of fluid biomarkers in delirium and advanced cancer-related syndromes.

Authors:  Ingrid Amgarth-Duff; Annmarie Hosie; Gideon Caplan; Meera Agar
Journal:  BMC Psychiatry       Date:  2020-04-22       Impact factor: 3.630

7.  Whole-body and adipose tissue metabolic phenotype in cancer patients.

Authors:  Lindsey J Anderson; Jonathan Lee; Barbara Anderson; Benjamin Lee; Dorota Migula; Adam Sauer; Nicole Chong; Haiming Liu; Peter C Wu; Atreya Dash; Yi-Ping Li; Jose M Garcia
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-01-28       Impact factor: 12.063

8.  Chemotherapy-induced cachexia and model-informed dosing to preserve lean mass in cancer treatment.

Authors:  Suzan Farhang-Sardroodi; Michael A La Croix; Kathleen P Wilkie
Journal:  PLoS Comput Biol       Date:  2022-03-21       Impact factor: 4.475

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.